Imatinib mesylate induces hypophosphatemia in patients with chronic myeloid leukemia in late chronic phase, and this effect is associated with response
- Osorio, S.
- García Noblejas, A.
- Durán, A.
- Steegmann, J.L.
ISSN: 0361-8609, 1096-8652
Année de publication: 2007
Volumen: 82
Número: 5
Pages: 394-395
Type: Article